SCHEMBL27397167

SCHEMBL27397167

[CH2]C(O)n1ccnc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28023189 0.79 CYP19A1 (0.45)
SCHEMBL13404115 0.79 CYP19A1 (0.45)
SCHEMBL3825883 0.79
SCHEMBL27874646 0.78 CYP19A1 (0.39)
SCHEMBL2990565 0.77
SCHEMBL76770 0.75
SCHEMBL5616569 0.75
SCHEMBL2456178 0.73 CYP19A1 (0.48)
SCHEMBL31582639 0.71 CYP19A1 (0.42)
SCHEMBL21634568 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101921236-A Can be used for treating 2 of neoplastic disease, inflammatory and disorder of immune system, 4-two (phenylamino) pyrimidine NOVARTIS AG 2010-12-22 CN claimed
CN-101687860-A Novel n- (8-heteroaryltetrahydronaphtalene-2yl) or n- (5- heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain ASTRAZENECA AB 2010-03-31 CN claimed
CN-100357275-C N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases ASTRAZENECA AB (SE) 2007-12-26 CN claimed
CN-101077865-A Phthalazines derivatives, preparation method thereof, medicament composition and use INST MATERIA MEDICA CAMS (CN) 2007-11-28 CN claimed
CN-1886378-A 1,4-disubstituted isoquinilone derivatives as RAF-kinase inhibitors useful for the treatment of proliferative diseases NOVARTIS AG (CH) 2006-12-27 CN claimed
CN-1854130-A Chinazoline derivative, its production, medicinal composition and use PHARMACEUTICAL INST CHINA ACAD (CN) 2006-11-01 CN claimed
CN-1832929-A 2, 4-pyrimidinediamines for the treatment of neoplastic diseases, inflammatory diseases and immune system disorders NOVARTIS AG (CH) 2006-09-13 CN claimed
CN-1788001-A 2, 4-bis (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders NOVARTIS AG (CH) 2006-06-14 CN claimed
CN-1243724-C Amide derivatives which are useful as cell factor inhibitors ASTRA ZENECA LTD (SE) 2006-03-01 CN claimed
CN-1639132-A N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases ASTRAZENECA AB (SE) 2005-07-13 CN claimed
CN-1185211-C Benzamide derivatives for the treatment of diseases caused by cytokines ASTRA ZENECA LTD (SE) 2005-01-19 CN claimed
CN-1161352-C Quinazoline derivatives 2004-08-11 CN claimed
CN-1100046-C Quinazoline derivatives ZENECA LTD (GB) 2003-01-29 CN claimed
CN-1330631-A Amide derivatives which are useful as cell factor inhibitors ASTRA ZENECA LTD (SE) 2002-01-09 CN claimed
CN-1322202-A Quinazoline derivatives ASTRA ZENECA N V (SE) 2001-11-14 CN claimed
CN-1321150-A Amide derivs. useful as inhibitors of production of cytokines ASTRAZENECA AB (SE) 2001-11-07 CN claimed
CN-1300278-A Benzamide derivatives for the treatment of diseases caused by cytokines ASTRA ZENECA LTD (SE) 2001-06-20 CN claimed
CN-1182421-A Quinazoline derivatives ZENECA LTD (GB) 1998-05-20 CN claimed
CN-103204781-A 2, 7-bi-substituted fluorenone derivative and preparation method and application thereof UNIV WUHAN 2013-07-17 CN disclosed
CN-1085546-A Aminediol protease inhibitors SQUIBB & SONS INC (US) 1994-04-20 CN disclosed